Table 2 Survival Data
Mean survival (months) ± SE | Five year survival (%) | P-value | |
|---|---|---|---|
Overall | 96.1 ± 3.5 | 63 | |
Age group | 0.005 | ||
< 30 | 46.9 ± 12.1 | 57 | |
30–39 | 62.1 ± 7.0 | 57 | |
40–49 | 87.3 ± 4.5 | 68 | |
50–54 | 96.2 ± 4.8 | 62 | |
Numerical Stage | < 0.001 | ||
I | 104.0 ± 5.0 | 94 | |
II | 102.4 ± 3.9 | 82 | |
III | 86.8 ± 4.0 | 67 | |
IV | 32.2 ± 4.6 | 18 | |
Sex | 0.212 | ||
Male | 99.3 ± 4.8 | 64 | |
Female | 81.1 ± 4.1 | 61 | |
Presentation Type | < 0.001 | ||
Elective | 90.1 ± 3.7 | 69 | |
Emergency | 61.0 ± 6.3 | 39 | |
Screening | 100.4 ± 5.1 | 82 |